GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC (XPAE:PHARMACARE) » Definitions » Cash from Discontinued Operating Activities

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Dec. 2021)


View and export this data going back to 2013. Start your Free Trial

What is Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Cash from Discontinued Operating Activities for the three months ended in Dec. 2021 was $0.00 Mil. It means Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals received $0.00 Mil from discontinued investing activities. Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2021 was $0.00 Mil.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Cash from Discontinued Operating Activities Historical Data

The historical data trend for Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Cash from Discontinued Operating Activities Chart

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cash from Discontinued Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Sep21 Dec21
Cash from Discontinued Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 677, Ramallah, PSE
Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC is engaged in the manufacturing, selling, distribution, export and import of medicines, cosmetics, chemicals and veterinary products.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Headlines

No Headlines